LIGAND PHARMACEUTICALS INCORPORATED
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $226.2M | $503.1M | $97.4M |
| FY2016 | $230.7M | $601.6M | $18.8M |
| FY2017 | $252.4M | $671.0M | $20.6M |
| FY2018 | $699.9M | $1.26B | $117.2M |
| FY2019 | $727.7M | $1.49B | $71.5M |
| FY2020 | $652.8M | $1.36B | $47.6M |
| FY2021 | $476.4M | $1.30B | $19.5M |
| FY2022 | $165.2M | $762.7M | $45.0M |
| FY2023 | $86.3M | $787.2M | $23.0M |
| FY2024 | $111.3M | $941.8M | $72.3M |